Principal Investigator
Ellen Koo
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221331
Clinical Trial Summary
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of
CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis Subjects
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Olufemi Sangoyomi
Phone Number
+1 (561) 3558985
Email
oas77@miami.edu